Anton Neschadim
Anton Neschadim
President & CEO, ImmunoBiochem Corporation
Verified email at
Cited by
Cited by
Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils
IK Campbell, S Miescher, DR Branch, PJ Mott, AH Lazarus, D Han, ...
The Journal of Immunology 192 (11), 5031-5038, 2014
Engineered human tmpk/AZT as a novel enzyme/prodrug axis for suicide gene therapy
T Sato, A Neschadim, M Konrad, DH Fowler, A Lavie, JA Medin
Molecular Therapy 15 (5), 962-970, 2007
Analog of H2 relaxin exhibits antagonistic properties and impairs prostate tumor growth
JD Silvertown, JC Symes, A Neschadim, T Nonaka, JCH Kao, ...
The FASEB Journal 21 (3), 754-765, 2007
A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation
A Neschadim, JA McCart, A Keating, JA Medin
Biology of Blood and Marrow Transplantation 13 (12), 1407-1416, 2007
A new pyrimidine-specific reporter gene: a mutated human deoxycytidine kinase suitable for PET during treatment with acycloguanosine-based cytotoxic drugs
Y Likar, J Zurita, K Dobrenkov, L Shenker, S Cai, A Neschadim, JA Medin, ...
Journal of Nuclear Medicine 51 (9), 1395-1403, 2010
Autologous transplantation of Lentivector/acid ceramidase–transduced hematopoietic cells in nonhuman Primates
JS Walia, A Neschadim, O Lopez-Perez, A Alayoubi, X Fan, S Carpentier, ...
Human gene therapy 22 (6), 679-687, 2011
Relaxin-3 and receptors in the human and rhesus brain and reproductive tissues
JD Silvertown, A Neschadim, HN Liu, P Shannon, JS Walia, JCH Kao, ...
Regulatory peptides 159 (1-3), 44-53, 2010
The engineered thymidylate kinase (TMPK)/AZT enzyme-prodrug axis offers efficient bystander cell killing for suicide gene therapy of cancer
T Sato, A Neschadim, A Lavie, T Yanagisawa, JA Medin
PLoS One 8 (10), e78711, 2013
Bystander killing of malignant cells via the delivery of engineered thymidine-active deoxycytidine kinase for suicide gene therapy of cancer
A Neschadim, JCM Wang, A Lavie, JA Medin
Cancer Gene Therapy 19 (5), 320-327, 2012
Extracellular histones identified in crocodile blood inhibit in-vitro HIV-1 infection
HN Kozlowski, ETL Lai, PC Havugimana, C White, A Emili, D Sakac, ...
Aids 30 (13), 2043-2052, 2016
Targeting the relaxin hormonal pathway in prostate cancer
A Neschadim, AJS Summerlee, JD Silvertown
International Journal of Cancer 137 (10), 2287-2295, 2015
Structure–activity relationships of pyrazole derivatives as potential therapeutics for immune thrombocytopenias
MK Purohit, SK Chakka, I Scovell, A Neschadim, AM Bello, N Salum, ...
Bioorganic & Medicinal Chemistry 22 (9), 2739-2752, 2014
Cytokine profiles in mouse models of experimental immune thrombocytopenia reveal a lack of inflammation and differences in response to intravenous immunoglobulin depending on …
D Leontyev, A Neschadim, DR Branch
Transfusion 54 (11), 2871-2879, 2014
Relaxin receptor antagonist AT-001 synergizes with docetaxel in androgen-independent prostate xenografts
A Neschadim, LB Pritzker, KPH Pritzker, DR Branch, AJS Summerlee, ...
Endocrine-Related Cancer 21 (3), 459-471, 2014
Cell fate control gene therapy based on engineered variants of human deoxycytidine kinase
A Neschadim, JCM Wang, T Sato, DH Fowler, A Lavie, JA Medin
Molecular Therapy 20 (5), 1002-1013, 2012
Mouse models of autoimmune diseases: immune thrombocytopenia
A Neschadim, D R Branch
Current pharmaceutical design 21 (18), 2487-2497, 2015
Disulfide linked pyrazole derivatives inhibit phagocytosis of opsonized blood cells
MK Purohit, I Scovell, A Neschadim, Y Katsman, DR Branch, LP Kotra
Bioorganic & medicinal chemistry letters 23 (8), 2324-2327, 2013
Engineered human Tmpk fused with truncated cell-surface markers: versatile cell-fate control safety cassettes
M Scaife, N Pacienza, BCY Au, JCM Wang, S Devine, E Scheid, CJ Lee, ...
Gene Therapy 20 (1), 24-34, 2013
Mouse models for immune‐mediated platelet destruction or immune thrombocytopenia (ITP)
A Neschadim, DR Branch
Current Protocols in Immunology 113 (1), 15.30. 1-15.30. 13, 2016
c-SRC protein tyrosine kinase regulates early HIV-1 infection post-entry
SDS McCarthy, D Sakac, A Neschadim, DR Branch
Aids 30 (6), 849-858, 2016
The system can't perform the operation now. Try again later.
Articles 1–20